glp-1 psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Emerging research suggests that GLP-1–based
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
![glp-1 psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Emerging research suggests that GLP-1based](https://gumlet.assettype.com/healthday-en/2025-06-23/rb1py4k4/AdobeStock1292661104.jpeg?width=600)
![glp-1 psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Emerging research suggests that GLP-1based](https://www.mdpi.com/diseases/diseases-13-00127/article_deploy/html/images/diseases-13-00127-g005-550.jpg)
![glp-1 psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Emerging research suggests that GLP-1based](https://cdn.sanity.io/images/0vv8moc6/dermatologytimes/8e282d6f45124a8e8c8f0c4db3aaf85d6cbcac1b-4058x2848.jpg)
![glp-1 psoriasis Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases Emerging research suggests that GLP-1based](https://images.prismic.io/npf-website/Z7YnEJ7c43Q3f-9T_AWHeroes.png?ixlib=gatsbyFP&auto=format%2Ccompress&fit=max&rect=0%2C33%2C1200%2C610&w=311&h=158)




















